January 31, 2010 Expert Opinions is a brand-new section on contractpharma.com!
This new feature will contain shorter opinion pieces (300-500 words) on pressing issues in pharma and biopharma outsourcing, manufacturing, trials, regulatory, technology and other heal…
January 25, 2010 Sinobiopharma’s production facility for solid dosage Perindopril has passed Chinese State Food and Drug Administration (SFDA) inspection and is now approved for production and marketing.
Eric S. Langer || January 22, 2010 The Future of Bio-Outsourcing
A new report explores bio-manufacturing trends
By Eric S. Langer
Biopharma companies are outsourcing more today than ever before, and, according to our recent study, the 7th Annual Report and Survey of Bio…
Gil Y. Roth || October 8, 2009 10 Years On: CRO Perspectives
By Gil Y. Roth
Contract Research Organizations have followed different paths and models over the past decade. We asked several of the major CROs about the biggest changes and trends they've seen in…
Eric S. Langer || September 3, 2009 Bio-Manufacturing Outsourcing Trends
A funding crunch in biotech creates an outsourcing dilemma
By Eric S. Langer
The current funding crunch has put the brakes on some new R&D projects, and slowed the development of others in the p…
Gil Y. Roth || September 3, 2009 I've done a bang-up job of staying out of this summer's rancorous "debates" over healthcare reform, and plan to stay on that path. So don't try to get me wound up.
The thing is, I don't doubt the sincerity of citizens on both sides of the is…
July 15, 2009 This edition of the Top 10 Biopharmas marks the end of an era. After this year, weâ€™ll no longer be able to pencil in Amgen as our #1 biopharma, since Roche is poised to take that slot. A lot of major pharmas have talked about â€śbecoming a global biopharma.
July 15, 2009 They donâ€™t call them â€śBig Pharmaâ€ť for nothing! Several of the industryâ€™s biggest players decided to get bigger via M&A this year, which means next yearâ€™s ranks are going to feature at least three new players, once Wyeth and Schering-Plough are swallowed up and Roche moves over to the Top Biopharma ranks. And I do mean top!